+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 89Years
All Genders
ID07140874

Study of Zinc Supplement to Extend the Effect of Botox Injections in Adults with Cervical Dystonia

Led by University of Florida · Updated on 2026-05-15

25

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether zinc supplementation can extend the benefits of botulinum toxin type A Botox injections in adults with cervical dystonia. This randomized, single-blind, crossover placebo-controlled trial focuses on patients who have been receiving regular Botox injections with good response. The study aims to assess the effectiveness, safety, and impact on quality of life and function for cervical dystonia patients receiving zinc citrate compared to a placebo. Participants will take either zinc citrate 30 mg or a matching placebo daily for three months, then switch to the other treatment for another three months. Botox injections will be administered every three months following their usual schedule. Blood tests will be conducted at the start and end of the study to measure zinc, vitamin B12 levels, and other health markers. During the six-month study period, participants will visit the clinic every three months for Botox injections, evaluations, and surveys about symptoms, pain, quality of life, and function. Researchers will monitor the duration of Botox effectiveness and overall safety throughout the trial. The study includes about 20 cervical dystonia patients aged 18 to 89 currently receiving Botox treatment.

CONDITIONS

Brief Title

Zinc as an Adjunctive Therapy for Cervical Dystonia

Research Team

J

Julie Segura, BA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here